SCHEMBL4737419

SCHEMBL4737419

Nc1nc2c(c(-c3ccc4[nH]ccc4c3)n1)-c1ccc(-c3cncnc3)cc1CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 3/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
LRRK2 Q5S007 4/20 0.37
PIP4K2A P48426 1/20 0.36
PIP4K2B P78356 1/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
CSNK1D P48730 1/20 0.35
MAPK11 Q15759 1/20 0.35
MAPK14 Q16539 1/20 0.35
ATR Q13535 1/20 0.35
NPC1 O15118 1/20 0.34
CYP17A1 P05093 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
PIK3CD O00329 2/20 0.34
ABL1 P00519 2/20 0.34
EGFR P00533 2/20 0.34
HCK P08631 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4737438 0.85 TYMS (0.47) MAP3K11CYP3A4CYP2D6LRRK2ADORA2A
SCHEMBL6655349 0.73 NPC1 (0.59) MAP3K11CYP3A4CYP2D6PIP4K2APIP4K2B
SCHEMBL846923 0.69 BRD4 (0.47) MAP3K11CYP3A4CYP2D6LRRK2ADORA2A
SCHEMBL4787500 0.64 TYMS (0.50) ADORA2AADORA1
SCHEMBL27612533 0.63 PIK3CD (0.46) MAP3K11CYP3A4CYP2D6LRRK2ADORA2A
SCHEMBL4737740 0.62 ADORA2A (0.46) ADORA2AADORA1CYP11B1CYP11B2
SCHEMBL5850255 0.62 NPC1 (0.79) MAP3K11NPC1CYP17A1CYP11B1CYP11B2
SCHEMBL4741259 0.60 TYMS (0.41) ADORA2AADORA1CYP11B1CYP11B2EGFR
SCHEMBL1640616 0.60 BRAF (0.58) ADORA2AADORA1CSNK1DMAPK11MAPK14
SCHEMBL4740440 0.60 TYMS (0.41) ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008086158-A1 BENZODIHYDROQUINAZOLINE AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-07-17 WO disclosed